Fortive Corporation has released a critical supplemental 8-K report providing unaudited financial metrics assuming the Precision Technologies segment, held by Ralliant Corporation, is classified as a discontinued operation. This anticipated separation, expected on June 28, 2025, positions Fortive as a more focused industrial growth entity and offers investors a clearer view of continuing operations excluding the PT segment.
Key financial highlights for continuing operations are as follows: Fortive posted total revenues of \(4.08 billion for the full year 2024, with \)3.29 billion attributed to sales of products and software and \(790 million from services. In the first quarter of 2025, total continuing operations revenue reached \)993.1 million, reflecting ongoing business strength.
On a non-GAAP basis, core revenue growth, which excludes impacts from currency fluctuations and acquired/divested businesses, was steady at 4.3% for 2024 and showed positive momentum of 2.2% in Q1 2025. Adjusted operating profit reached a robust $1.10 billion in 2024 with an operating margin of 26.9%, indicating efficient cost management and operational improvements inside the Intelligent Operating Solutions and Advanced Healthcare Solutions segments. Adjusted EBITDA margin also strengthened steadily to 28.5% in 2024.
Liquidity remains robust, with cash and cash equivalents increasing to \(885.9 million as of March 28, 2025, compared to \)808.1 million at year-end 2024. Fortive’s balance sheet shows strong total assets of \(17.14 billion against total liabilities of \)6.89 billion, ensuring solid capital structure and capacity for growth investments.
Notable one-time items include the Russia exit and wind down costs of \(15.6 million in 2022, fully excluded from adjusted financials, and a charitable contribution expense of \)20 million in Q1 2024 reflecting corporate social responsibility commitments.
The strategic separation of Ralliant is aligned with Fortive’s ongoing portfolio optimization strategy emphasized in recent earnings calls, underlining resilience amid global economic uncertainties such as tariff impacts and trade policies. This structural shift is expected to sharpen Fortive’s focus on its higher-growth segments, potentially enhancing margin profiles and revenue growth trajectories.
Investors should closely monitor forthcoming earnings releases to assess the impact of Ralliant’s separation on Fortive’s financials, and the company’s continued execution on efficiency and growth initiatives within the industrial technology space.
In conclusion, Fortive stands on firm financial ground with a forward-looking approach centered on innovation in Intelligent Operating Solutions and Advanced Healthcare sectors. The company’s non-GAAP adjusted earnings per share from continuing operations recorded an impressive $2.41 for 2024, highlighting effective capitalization on sector-specific growth drivers such as digitalization and automation.
For further details and to access the full source document, please visit Fortive Corporation’s official 8-K filing.
Tags: FORT, Fortive Corporation, Q1 2025, industrial technology growth, core revenue expansion, financial health